Research and analysis

COVID-19: impact on STIs, HIV and viral hepatitis

Report assessing the impact of the COVID-19 pandemic on prevention, testing, diagnosis and care for STIs, HIV and hepatitis in England.

• From: Public Health England
• Published: 15 December 2020

Applies to England

Documents

Impact of COVID-19 on STIs, HIV and viral hepatitis in England: 2020 report (provisional data)

Ref: PHE publications gateway number: GW-1789

PDF, 1.73 MB, 38 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Impact of COVID-19 on STIs, HIV and viral hepatitis in England: 2020 appendix (provisional data)

Ref: PHE publications gateway number: GW-1789

PDF, 1.66 MB, 32 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This report presents the results of analyses of national surveillance data to assess the impact of the coronavirus (COVID-19) pandemic to-date on sexually transmitted infection (STI), HIV and viral hepatitis service provision and epidemiology.

Provisional data are presented up to June, August or September 2020, depending on the data source.

Published 15 December 2020